Stockreport

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Could Be 48% Below Their Intrinsic Value Estimate [Yahoo! Finance]

Vertex Pharmaceuticals Incorporated  (VRTX) 
Last vertex pharmaceuticals incorporated earnings: 4/29 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.vrtx.com
PDF Current share price of US$448 suggests Vertex Pharmaceuticals is potentially 48% undervalued Analyst price target for VRTX is US$514 which is 40% below our fair value [Read more]